Technology Maturation to Enhance Future Platform Lethality
Oshkosh Defense and the US Army Combat Capabilities Development Command (DEVCOM) have agreed on a Cooperative Research and Development Agreement (CRADA) to cooperate in the development, integration and test of innovative weapons technologies aimed at providing transformative, next-generation lethality.
The agreement will enable both parties to mature technologies for transition to platforms such as the Optionally Manned Fighting Vehicle (OMFV). Development activities will leverage the proven Oshkosh Defense Stryker Medium Caliber Weapon System (MCWS) 30mm turret. “We are already starting with a robust weapon system platform with our Stryker MCWS turret,” said Pat Williams, Oshkosh VP/GM of US Army and Marine Corps Programs. “This CRADA allows us to explore additional weapon system capabilities and apply them to our OMFV solution to provide our soldiers with the cutting-edge technology required on the modern battlefield.”
Last June, the Army selected Oshkosh Defense, Pratt Miller Defense, and Rafael Advanced Defense Systems to provide a precision lethality capability for their Stryker Brigade Combat Teams (SBCTs), as part of the Stryker MCWS programme. Production of the Stryker MCWS is expected to begin imminently. In July 2021, the Army also selected Oshkosh Defense to participate in the OMFV Concept Design Phase, which culminates in Q1/FY23, and in which the company has partnered with Pratt Miller Defense, Hanwha Defense USA, Rafael Advanced Defense Systems, QinetiQ Inc., and Plasan.